Amova Asset Management Americas, Inc.

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1480751 NEW YORK, NY

Back to BCRX Full portfolio

Position in BCRX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$25,750

New position

Shares Held

2,575

first reported quarter

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#271

of 316 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Amova Asset Management Americas, Inc. holds $191,527 across 4 Drug Manufacturers - Specialty & Generic names. BCRX ranks #4 (13.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMRX	Amneal Pharmaceuticals, Inc.	3,339	$57,798
2	SUPN	Supernus Pharmaceuticals, Inc.	1,166	$54,230
3	INDV	Indivior Pharmaceuticals, Inc.	1,310	$53,749
4	BCRX	Biocryst Pharmaceuticals Inc This page	2,575	$25,750

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$25,750	2,575	—	Shares	Sole	2026-08-13
No filing history on record for this holder in this stock.

Amova Asset Management Americas, Inc.

Position in BCRX

Position in Drug Manufacturers - Specialty & Generic

All Filings in BCRX